During the 20th International Myeloma Society Annual Meeting 2023, the Multiple Myeloma Hub was pleased to speak to Krina Patel, MD Anderson Cancer Center, Houston, US. We asked, How might intravenous immunoglobulin therapy (IVIG) therapy be used to treat infection after B-cell maturation antigen (BCMA)-targeted therapies in MM?

In this interview Krina Patel opens by explaining how BCMA-targeted therapies, used to treat MM, can result in a higher rate of infection. Patel then goes on to explain the applications of IVIG to treat these infections, outlining which patients the treatment is most appropriate for, as well as the recommended dosing regimens. Patel concludes by discussing alternative methods for prophylaxis and treatment of infections in MM.